Innovative Cardiovascular Solutions LLC, the developer of a device to improve patient safety during a heart procedure, closed on $8 million in capital raised to support clinical trials and production.
The $8 million that Innovative Cardiovascular Solutions LLC wants to raise in a new capital round would support completion of a clinical trial in Europe and pay for an upcoming U.S. trial.
The amount of venture capital invested in biotech and health care startups based in Michigan nearly doubled in 2017.
The number of venture capital deals in Michigan held relatively steady through the third quarter of 2017 compared to the same period a year earlier, although the amount invested declined.
Michigan ranked third among 11 Midwest regions for the value of equity investments made in life sciences companies during the first half of 2017.
KALAMAZOO — Innovative Cardiovascular Solutions LLC will support further development of its medical device thanks to $5 million in new capital it raised from angel investors.
Innovative Cardiovascular Solutions LLC raised $5 million in Series B capital that will support further development of a device used in heart procedures.
KALAMAZOO — The launch of a clinical trial in Europe brings a Southwest Michigan medical device startup a step close to the marketplace and an eventual sale.
At some point in the coming months, Mark Gurney and directors at Tetra Discovery Partners LLC will decide which road to travel into the future for their company.
Venture capital investments in Midwest health sciences companies ballooned during the first half of 2016, both in terms of deal flow and dollar value.